Knowledge Distillery

Persistent symptoms after COVID-19 constitute the long COVID syndrome, also called post-acute sequelae of SARS-CoV-2 infection (PASC). COVID-19…

There are concerns for safety regarding SARS-CoV-2 vaccines for patients with autoimmune neuromuscular disease. In this substudy of a prospective…

Demyelinating diseases including multiple sclerosis are associated with prior infectious exposures. In this article the authors assessed whether…

Post-mortem studies have shown that patients dying from SARS-CoV-2 infection frequently have pathological changes in their CNS, particularly in the…

Messenger RNA (mRNA) vaccines provide robust protection against SARS-CoV-2 in healthy individuals. However, immunity after vaccination of patients…

The COVID-19 pandemic raised concern amongst clinicians that disease-modifying therapies (DMT), particularly anti-CD20 monoclonal antibodies (mAb) and…

In 2024, the sequalae of the acute phase of coronavirus disease-19 (COVID-19) infection, which include neurological symptoms and are commonly referred…

Between 2.5% and 28% of people infected with SARS-CoV-2 suffer long COVID or persistence of symptoms for months after acute illness. Many symptoms are…

Previous reports and meta-analyses derived from small case series reported a mortality rate of up to 40% in patients with coronavirus disease 2019…

COVID-19 patients commonly present with signs of central nervous system and/or peripheral nervous system dysfunction. In this study, the authors show…

Although some studies have shown neuroimaging and neuropsychological alterations in post-COVID-19 patients, fewer combined neuroimaging and…

The purpose of this prospective cohort study was to evaluate the possible correlation between SARS-CoV-2 vaccines and the onset of neurological…